{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:18:35Z","timestamp":1761718715583,"version":"build-2065373602"},"reference-count":125,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.mycmed.2018.04.011","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T07:47:12Z","timestamp":1536306432000},"page":"574-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Epidemiology of antifungal susceptibility: Review of literature"],"prefix":"10.1016","volume":"28","author":[{"given":"I.","family":"Hadrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ayadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2018.04.011_bib0635","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jac\/42.4.497","article-title":"In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis","volume":"42","author":"Lass-Florl","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0640","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3109\/13693786.2012.684154","article-title":"Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection","volume":"50","author":"Hadrich","year":"2012","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0645","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0650","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0655","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3201\/eid1801.110556","article-title":"Candida spp. with acquired echinocandin resistance, France, 2004\u20132010","volume":"18","author":"Dannaoui","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0660","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1128\/AAC.00477-13","article-title":"Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications","volume":"57","author":"Forastiero","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0665","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/AAC.00335-08","article-title":"In vitro activities of various antifungal drugs against Aspergillus terreus: global assessment using the methodology of the European committee on antimicrobial susceptibility testing","volume":"53","author":"Lass-Florl","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0670","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1439-0507.2002.00797.x","article-title":"Aspergillus nidulans is frequently resistant to amphotericin B","volume":"45","author":"Kontoyiannis","year":"2002","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0675","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3767\/003158509X418925","article-title":"Polyphasic taxonomy of the heat resistant ascomycete genus Byssochlamys and its Paecilomyces anamorphs","volume":"22","author":"Samson","year":"2009","journal-title":"Persoonia"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0680","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jac\/dkh489","article-title":"Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay","volume":"55","author":"Balajee","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0685","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ja.2015.29","article-title":"Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010\u20132012)","volume":"68","author":"Pfaller","year":"2015","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0690","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1128\/AAC.00854-09","article-title":"Transcriptional regulation of chitin synthases by calcineurin controls paradoxical growth of Aspergillus fumigatus in response to caspofungin","volume":"54","author":"Fortwendel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0695","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmi.2016.09.016","article-title":"Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia","volume":"23","author":"Rueda","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0700","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1128\/AAC.00530-09","article-title":"Trailing or paradoxical growth of Candida albicans when exposed to caspofungin is not associated with microsatellite genotypes","volume":"54","author":"Khlif","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0705","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1099\/jmm.0.076000-0","article-title":"Trailing or paradoxical growth of Aspergillus flavus exposed to caspofungin is independent of genotype","volume":"63","author":"Hadrich","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0710","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2193-1801-3-19","article-title":"In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia","volume":"3","author":"Gheith","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0715","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1128\/JCM.40.10.3841-3844.2002","volume":"40","author":"Chryssanthou","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0720","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/JCM.00490-12","article-title":"Interlaboratory reproducibility of Etest amphotericin B and caspofungin yeast susceptibility testing and comparison with the CLSI method","volume":"50","author":"Ranque","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0725","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1128\/JCM.00925-15","article-title":"Comparing Etest and broth microdilution for antifungal susceptibility testing of the most-relevant pathogenic molds","volume":"53","author":"Lamoth","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0730","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0735","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/AAC.01256-09","article-title":"Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media","volume":"54","author":"Arendrup","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0740","first-page":"e1","article-title":"EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents, Clin Microbiol Infect","volume":"22","author":"Arendrup","year":"2016"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0745","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","author":"van der Linden","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0750","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/AAC.01024-06","article-title":"Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro","volume":"51","author":"Perkhofer","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0755","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1128\/JCM.01840-06","article-title":"Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents","volume":"45","author":"Alexander","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0760","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1128\/JCM.01230-13","article-title":"Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne method","volume":"51","author":"Canton","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0765","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1128\/JCM.02316-09","volume":"48","author":"Cuenca-Estrella","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2014.12.033","article-title":"Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013","volume":"33","author":"Zhang","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0775","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jac\/dkn015","article-title":"Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations","volume":"61","author":"Xu","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0780","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2515\/therapie\/2014059","article-title":"Changes in genotype and fluconazole susceptibility of isolates from patients with Candida glabrata in Tunisia","volume":"69","author":"Abbes","year":"2014","journal-title":"Therapie"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0785","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fcimb.2013.00074","article-title":"Interactions between copy number and expression level of genes involved in fluconazole resistance in Candida glabrata","volume":"3","author":"Abbes","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0790","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/13693786.2013.800239","article-title":"Identification and antifungal susceptibility of a large collection of yeast strains isolated in Tunisian hospitals","volume":"51","author":"Eddouzi","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0795","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1128\/JCM.01627-12","article-title":"Characterization of a new clinical yeast species, Candida tunisiensis sp. nov., isolated from a strain collection from Tunisian hospitals","volume":"51","author":"Eddouzi","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0800","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/13693780802291445","article-title":"The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study","volume":"47","author":"Kim","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0805","doi-asserted-by":"crossref","first-page":"e0118770","DOI":"10.1371\/journal.pone.0118770","article-title":"Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage","volume":"10","author":"Won","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0810","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/myc.12299","article-title":"In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012","volume":"58","author":"Pfaller","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0815","first-page":"DC11","article-title":"Caspofungin MIC Distribution amongst Commonly Isolated Candida Species in a Tertiary Care Centre - An Indian Experience","volume":"10","author":"Wanjare","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0820","doi-asserted-by":"crossref","first-page":"e34151","DOI":"10.5812\/jjm.34151","article-title":"Microdilution in vitro antifungal susceptibility patterns of Candida Species, from mild cutaneous to bloodstream infections","volume":"9","author":"Rezazadeh","year":"2016","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0825","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1111\/j.1439-0507.2011.02165.x","article-title":"Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study","volume":"55","author":"Schmalreck","year":"2012","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0830","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.diagmicrobio.2014.05.021","article-title":"Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility","volume":"81","author":"Nieto","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0835","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/AAC.00285-15","article-title":"Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital","volume":"59","author":"Posteraro","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0840","doi-asserted-by":"crossref","first-page":"217","DOI":"10.33073\/pjm-2014-028","article-title":"Trends in antifungal susceptibility of Candida species--one year observation","volume":"63","author":"Golas","year":"2014","journal-title":"Pol J Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0845","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s11046-016-0052-1","article-title":"Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: first description of Candida nivariensis in Argentina","volume":"181","author":"Morales-Lopez","year":"2016","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0850","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.diagmicrobio.2014.11.008","article-title":"In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species","volume":"81","author":"Pfaller","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0855","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bjm.2016.01.005","article-title":"Susceptibility and molecular characterization of Candida species from patients with vulvovaginitis","volume":"47","author":"Fornari","year":"2016","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0860","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1128\/JCM.00319-11","article-title":"First three reported cases of nosocomial fungemia caused by Candida auris","volume":"49","author":"Lee","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0865","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10096-013-2027-1","article-title":"Multidrug-resistant endemic clonal strain of Candida auris in India","volume":"33","author":"Chowdhary","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0870","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3201\/eid2007.131765","article-title":"Candida auris-associated candidemia, South Africa","volume":"20","author":"Magobo","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0875","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jinf.2016.07.008","article-title":"First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia","volume":"73","author":"Calvo","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0880","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00189-16","article-title":"Comparative pathogenicity of united kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species","volume":"1","author":"Borman","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0885","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3201\/eid2106.150270","article-title":"Candida auris candidemia in Kuwait, 2014","volume":"21","author":"Emara","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0890","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0895","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3201\/eid2301.161497","article-title":"Invasive infections with multidrug-resistant yeast Candida auris, Colombia","volume":"23","author":"Morales-Lopez","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0900","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/myc.12543","article-title":"Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville","volume":"60","author":"Gago","year":"2017","journal-title":"Spain, Mycoses"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0905","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1469-0691.2008.02021.x","article-title":"In vitro susceptibility of Cryptococcus gattii clinical isolates","volume":"14","author":"Gomez-Lopez","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0910","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/myc.12171","article-title":"Molecular epidemiology and antifungal susceptibility of Serbian Cryptococcus neoformans isolates","volume":"57","author":"Arsic Arsenijevic","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0915","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.riam.2014.01.005","article-title":"Molecular characterization and antifungal susceptibility of Cryptococcus neoformans strains collected from a single institution in Lima, Peru","volume":"32","author":"Bejar","year":"2015","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0920","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2334-10-289","article-title":"Microsatellite typing and susceptibilities of serial Cryptococcus neoformans isolates from Cuban patients with recurrent Cryptococcal meningitis","volume":"10","author":"Illnait-Zaragozi","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0925","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/S1678-9946201658069","article-title":"Antifungal susceptibility testing and genotyping characterization of Cryptococcus neoformans AND gattii Isolates from hiv-infected patients of Ribeirao Preto, Sao Paulo, Brazil","volume":"58","author":"Figueiredo","year":"2016","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0930","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s10096-016-2731-8","article-title":"Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6\/VGII) isolates from Southern Brazil","volume":"35","author":"Herkert","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0935","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s10096-011-1488-3","article-title":"Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities","volume":"31","author":"Matos","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0940","first-page":"680","article-title":"Diversity and antifungal drug susceptibility of Cryptococcus isolates in Thailand","volume":"55","author":"Worasilchai","year":"2017","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1040841X.2011.606426","article-title":"Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update","volume":"38","author":"Chowdhary","year":"2017","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0950","first-page":"696","article-title":"Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility, Clin Microbiol Infect","volume":"16","author":"Liaw","year":"2010"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0955","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1099\/jmm.0.000265","article-title":"Cryptococcus neoformans isolates from Yaounde human immunodeficiency virus-infected patients exhibited intra-individual genetic diversity and variation in antifungal susceptibility profiles between isolates from the same patient","volume":"65","author":"Kammalac Ngouana","year":"2016","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0960","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.diagmicrobio.2016.08.004","article-title":"In vitro antifungal susceptibility profiles of Cryptococcus species isolated from HIV-associated cryptococcal meningitis patients in Zimbabwe","volume":"86","author":"Nyazika","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0965","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/myc.12556","article-title":"Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies","volume":"60","author":"Rojas","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0970","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00403-016-1701-4","article-title":"Ketoconazole inhibits Malassezia furfur morphogenesis in vitro under filamentation optimized conditions","volume":"309","author":"Youngchim","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0975","first-page":"72","article-title":"Genotyping and antifungal susceptibility testing of multiple Malassezia pachydermatis isolates from otitis and dermatitis cases in pets: is it really worth the effort?","volume":"54","author":"Alvarez-Perez","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0980","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.vetmic.2012.04.034","article-title":"Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocol","volume":"159","author":"Cafarchia","year":"2012","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0985","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/13693786.2012.674219","article-title":"In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods","volume":"50","author":"Cafarchia","year":"2012","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0990","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.vetmic.2011.09.008","article-title":"In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions","volume":"155","author":"Cafarchia","year":"2012","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib0995","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11046-015-9913-2","article-title":"Agar diffusion procedures for susceptibility testing of Malassezia pachydermatis: evaluation of Mueller-Hinton agar plus 2% glucose and 0.5 microg\/ml methylene blue as the test medium","volume":"180","author":"Pasquetti","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1000","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1590\/S1517-83822009000200002","article-title":"CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazole","volume":"40","author":"Nascente Pda","year":"2009","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijantimicag.2006.09.016","article-title":"Antifungal activities of azole agents against the Malassezia species","volume":"29","author":"Miranda","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1010","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/JCM.43.6.2824-2829.2005","article-title":"Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species","volume":"43","author":"Sugita","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1015","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/JCM.38.3.992-995.2000","article-title":"Molecular analysis of CAP59 gene sequences from five serotypes of Cryptococcus neoformans","volume":"38","author":"Nakamura","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1020","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3109\/13693786.2013.800240","article-title":"Genotype analysis based on intergenic spacer 1 sequences of Trichosporon asahii collected in Taiwan","volume":"51","author":"Yang","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1025","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1099\/jmm.0.049817-0","article-title":"Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing","volume":"61","author":"Sun","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1099\/jmm.0.000442","article-title":"First genotype identification of Trichosporon asahii in Sfax-Tunisia","volume":"66","author":"Sellami","year":"2017","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1035","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.12511","article-title":"Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India","volume":"59","author":"Rastogi","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1040","first-page":"518","article-title":"Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen","volume":"55","author":"Dabas","year":"2017","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1045","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bjid.2016.08.008","article-title":"Antifungal activities of tacrolimus in combination with antifungal agents against fluconazole-susceptible and fluconazole-resistant Trichosporon asahii isolates","volume":"20","author":"Kubica","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1050","first-page":"62","article-title":"Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients","volume":"48","author":"Almeida","year":"2016","journal-title":"Rev Argent Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1055","doi-asserted-by":"crossref","first-page":"e109553","DOI":"10.1371\/journal.pone.0109553","article-title":"Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B","volume":"9","author":"Iturrieta-Gonzalez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1060","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/1469-0691.12501","article-title":"Sequence-based identification, genotyping and EUCAST antifungal susceptibilities of Trichosporon clinical isolates from Greece","volume":"20","author":"Arabatzis","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1065","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/mmy\/myv009","article-title":"Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients","volume":"53","author":"Montoya","year":"2015","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jac\/dkf045","article-title":"Echinocandins: a new class of antifungal","volume":"49","author":"Denning","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1075","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21\u201322","author":"Verweij","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1085","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MJT.0b013e3181a1afb7","article-title":"The effect of time to antifungal therapy on mortality in Candidemia associated septic shock","volume":"16","author":"Patel","year":"2009","journal-title":"Am J Ther"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1090","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1128\/AAC.00585-09","article-title":"Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri","volume":"53","author":"Alcazar-Fuoli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1095","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/AAC.00383-13","article-title":"Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study)","volume":"57","author":"Alastruey-Izquierdo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11046-015-9969-z","article-title":"Time-kill kinetics and in vitro antifungal susceptibility of non-fumigatus Aspergillus species isolated from patients with ocular mycoses","volume":"181","author":"Oz","year":"2016","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1105","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/JCM.02012-16","article-title":"Multilocus phylogeny and antifungal susceptibility of Aspergillus section circumdati from clinical samples and description of A.\u00a0pseudosclerotiorum sp. nov","volume":"55","author":"Siqueira","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1110","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/mmy\/myw024","article-title":"Antifungal susceptibility of 175 Aspergillus isolates from various clinical and environmental sources","volume":"54","author":"Sabino","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1115","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12324","article-title":"Multi-triazole-resistant Aspergillus fumigatus infections in Australia","volume":"58","author":"Kidd","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1120","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.3314\/mmj.16-00016","article-title":"The first isolation of Aspergillus allahabadii from a cormorant with pulmonary aspergillosis","volume":"57","author":"Lim","year":"2016","journal-title":"Med Mycol J"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1125","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3343\/alm.2015.35.6.602","article-title":"Molecular identification and amphotericin B susceptibility testing of clinical isolates of Aspergillus from 11 hospitals in Korea","volume":"35","author":"Heo","year":"2015","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11046-015-9939-5","article-title":"Clinical and laboratory features of six cases of Candida and dermatophyte folliculitis and a review of published studies","volume":"181","author":"Durdu","year":"2016","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1135","first-page":"32","article-title":"In vitro antifungal activities against moulds isolated from dermatological specimens","volume":"23","author":"Mohd Nizam","year":"2016","journal-title":"Malays J Med Sci"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5152\/eajm.2014.05","article-title":"Investigation of in vitro activity of five antifungal drugs against dermatophytes species isolated from clinical samples using the E-Test Method","volume":"46","author":"Aktas","year":"2014","journal-title":"Eurasian J Med"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1145","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/AAC.04381-14","article-title":"Evaluation of a modified EUCAST fragmented-mycelium inoculum method for in vitro susceptibility testing of dermatophytes and the activity of novel antifungal agents","volume":"59","author":"Risslegger","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.mycmed.2018.04.011_bib1150","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jdv.12151","article-title":"Identification and antifungal susceptibility of fungi isolated from dermatomycoses","volume":"28","author":"Silva","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1155","first-page":"2557","article-title":"Isolation, identification, and in vitro antifungal susceptibility testing of dermatophytes from clinical samples at Sohag University Hospital in Egypt","volume":"8","author":"Shalaby","year":"2016","journal-title":"Electron Phys"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1160","first-page":"36","article-title":"Antifungal susceptibility and virulence factors of clinically isolated dermatophytes in Tehran, Iran","volume":"8","author":"Afshari","year":"2016","journal-title":"Iran J Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1165","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1128\/JCM.00960-16","article-title":"Identification and antifungal susceptibility of Penicillium-like fungi from clinical samples in the United States","volume":"54","author":"Guevara-Suarez","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1007245226495","article-title":"Penicillium marneffei: types and drug susceptibility","volume":"149","author":"Imwidthaya","year":"2001","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijantimicag.2016.07.005","article-title":"Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations","volume":"48","author":"Halliday","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.riam.2014.06.005","article-title":"Fungal necrotizing fasciitis, an emerging infectious disease caused by Apophysomyces (Mucorales)","volume":"32","author":"Chander","year":"2015","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1185","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1128\/AAC.00004-15","article-title":"Etest cannot be recommended for in vitro susceptibility testing of mucorales","volume":"59","author":"Caramalho","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1190","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/jac\/dks137","article-title":"In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs","volume":"67","author":"Drogari-Apiranthitou","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1195","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/jac\/dkr297","article-title":"In vitro interaction of caspofungin and immunosuppressives against agents of mucormycosis","volume":"66","author":"Thakur","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1200","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1179\/joc.2009.21.3.272","article-title":"In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries","volume":"21","author":"Verweij","year":"2009","journal-title":"J Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/JCM.06133-11","article-title":"Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales","volume":"50","author":"Vitale","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mycmed.2015.12.002","article-title":"In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae","volume":"26","author":"Kachuei","year":"2016","journal-title":"J Mycol Med"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1215","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.02456-15","article-title":"International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for fusarium species identified by molecular methods for the CLSI broth microdilution method","volume":"60","author":"Espinel-Ingroff","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11046-016-9983-9","article-title":"Genotyping of Fusarium isolates from onychomycoses in Colombia: detection of two new species within the fusarium solani species complex and in vitro antifungal susceptibility testing","volume":"181","author":"Guevara-Suarez","year":"2016","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1225","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajo.2013.10.004","article-title":"In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial","volume":"157","author":"Lalitha","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1230","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s10096-014-2111-1","article-title":"European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe","volume":"33","author":"Tortorano","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1235","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.diagmicrobio.2012.05.009","article-title":"Isothermal microcalorimetry for antifungal susceptibility testing of Mucorales, Fusarium spp., and Scedosporium spp","volume":"73","author":"Furustrand Tafin","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1240","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/AAC.01467-08","article-title":"Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers","volume":"53","author":"Alastruey-Izquierdo","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1245","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/AAC.01177-06","article-title":"Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates","volume":"51","author":"Alastruey-Izquierdo","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1250","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1128\/AAC.01160-07","article-title":"In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans","volume":"52","author":"Cuenca-Estrella","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.04.011_bib1255","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11046-016-0014-7","article-title":"Genotyping and in vitro antifungal susceptibility testing of Fusarium isolates from onychomycosis in India","volume":"181","author":"Gupta","year":"2016","journal-title":"Mycopathologia"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523317303669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523317303669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:19:28Z","timestamp":1761110368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523317303669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":125,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1156523317303669"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2018.04.011","relation":{},"ISSN":["1156-5233"],"issn-type":[{"type":"print","value":"1156-5233"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of antifungal susceptibility: Review of literature","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2018.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}